Identification of Novel Compounds Targeting the Liver X Receptor (LXR): In-silico Studies, Screening, Molecular Docking, and Chemico-pharmacokinetic Analysis DOI Open Access
Sarder Arifuzzaman,

Zubair Khalid Labu,

Md. Harun -Or- Rashid

и другие.

Biomedical & Pharmacology Journal, Год журнала: 2024, Номер 17(3), С. 1499 - 1522

Опубликована: Сен. 30, 2024

Studies have demonstrated the association between LXR activity dysregulation with many diseases, including atherosclerosis, diabetes and cancer. In recent years, several agonists surfaced, but none been approved for human use due to adverse effects or unforeseen reasons. this study, we first analysed mRNA protein expression of LXRs across tissues, network pathway analysis, reinterpreted their physiological function disease by utilizing multiple biological data repositories, RNA-seq atlas, DisGeNET, etc. Then, performed ligand-based virtual screening, chemico-pharmacokinetic docking simulation identify potential new compounds. Our findings mRNA, expression, enrichment analysis reveal diverse functions addressing possibility pharmacological manipulation small molecules would provide therapeutic strategies management. Evaluation properties directed selection LXR-623 AZ876 as promising candidates LXR-α LXR-β further in-silico investigation. Comprehensive screening ligands targeting based on chemical structures AZ876, identified ZINC000005399501 ZINC000021912941 highest binding affinity (−9.8 −10.7 kcal/mol) LXRα LXRβ, respectively. results also supported in along favorable features.

Язык: Английский

Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle DOI
Hayder M. Al‐kuraishy, Majid S. Jabir,

Ali K. Albuhadily

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102233 - 102233

Опубликована: Фев. 14, 2024

Язык: Английский

Процитировано

17

The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation DOI Open Access

Haydar M. Al‐kuraishy,

Majid S. Jabir,

Ali K. Albuhadily

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 91, С. 102084 - 102084

Опубликована: Окт. 5, 2023

Язык: Английский

Процитировано

32

Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Molecular Medicine, Год журнала: 2023, Номер 29(1)

Опубликована: Окт. 25, 2023

Abstract Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins, lipids and damaged organelles the lysosomes for degradation elimination. The mechanistic target of rapamycin (mTOR) main negative regulator autophagy. mTOR pathway involved in regulating neurogenesis, synaptic plasticity, neuronal development excitability. Exaggerated activity associated with temporal lobe epilepsy, genetic acquired experimental epilepsy. In particular, complex 1 (mTORC1) mainly epileptogenesis. investigation autophagy’s involvement epilepsy has recently been conducted, focusing on critical role rapamycin, autophagy inducer, reducing severity induced seizures animal model studies. induction could be innovative therapeutic strategy managing Despite protective against epileptogenesis its status epilepticus (SE) perplexing might beneficial or detrimental. Therefore, present review aims revise possible

Язык: Английский

Процитировано

29

BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy DOI Creative Commons

Naif H. Ali,

Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(10)

Опубликована: Май 1, 2024

Parkinson's disease (PD) is a neurodegenerative disorder of the brain and manifested by motor non-motor symptoms because degenerative changes in dopaminergic neurons substantia nigra. PD neuropathology associated with mitochondrial dysfunction, oxidative damage apoptosis. Thus, modulation apoptosis growth factors could be novel boulevard management PD. Brain-derived neurotrophic factor (BDNF) its receptor tropomyosin kinase type B (TrkB) are chiefly involved neuropathology. BDNF promotes survival nigra enhances functional activity striatal neurons. Deficiency TrkB triggers degeneration accumulation α-Syn As well, BDNF/TrkB signalling reduced early phase Targeting specific activators may attenuate this review aimed to discuss potential role against In conclusion, decreased linked severity long-term complications. Activation

Язык: Английский

Процитировано

15

New insight on the possible role of statins in Vascular Parkinsonism: A need for presumptive therapy DOI
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali I. Al‐Gareeb

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 95, С. 102209 - 102209

Опубликована: Янв. 28, 2024

Язык: Английский

Процитировано

14

The classical and non-classical axes of renin-angiotensin system in Parkinson disease: The bright and dark side of the moon DOI
Hayder M. Al‐kuraishy,

Sadiq M. Al‐Hamash,

Majid S. Jabir

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 94, С. 102200 - 102200

Опубликована: Янв. 17, 2024

Язык: Английский

Процитировано

10

The conceivable role of prolactin hormone in Parkinson disease: The same goal but with different ways DOI

Haydar M. Al‐kuraishy,

Majid S. Jabir, Ali I. Al‐Gareeb

и другие.

Ageing Research Reviews, Год журнала: 2023, Номер 91, С. 102075 - 102075

Опубликована: Сен. 14, 2023

Язык: Английский

Процитировано

21

Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated DOI Open Access

G.D. Kim,

Jiyoon Lee, Joohun Ha

и другие.

Nutrients, Год журнала: 2023, Номер 15(24), С. 5082 - 5082

Опубликована: Дек. 12, 2023

Endoplasmic reticulum (ER) stress plays a pivotal role in adipogenesis, which encompasses the differentiation of adipocytes and lipid accumulation. Sustained ER has potential to disrupt signaling unfolded protein response (UPR), thereby influencing adipogenesis. This comprehensive review illuminates molecular mechanisms that underpin interplay between We delve into dysregulation UPR pathways, namely, IRE1-XBP1, PERK ATF6 relation adipocyte differentiation, metabolism, tissue inflammation. Moreover, we scrutinize how impacts key adipogenic transcription factors such as proliferator-activated receptor γ (PPARγ) CCAAT-enhancer-binding proteins (C/EBPs) along with their interaction other pathways. The cellular ramifications include alterations adipokines, aged adipose also discuss roles chaperones cyclophilin A B play By shedding light on intricate relationship this paves way for devising innovative therapeutic interventions.

Язык: Английский

Процитировано

17

The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat? DOI Creative Commons
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb

и другие.

Journal of Cellular and Molecular Medicine, Год журнала: 2024, Номер 28(12)

Опубликована: Июнь 1, 2024

Abstract Parkinson disease (PD) is one of the most common neurodegenerative diseases brain. Of note, brain renin‐angiotensin system (RAS) intricate in PD neuropathology through modulation oxidative stress, mitochondrial dysfunction and neuroinflammation. Therefore, RAS by angiotensin receptor blockers (ARBs) angiotensin‐converting enzyme inhibitors (ACEIs) may be effective reducing risk neuropathology. It has been shown that all components including peptides enzymes are present different areas. Brain plays a critical role regulation memory cognitive function, controlling central blood pressure. However, exaggerated implicated pathogenesis PD. Two well‐known pathways recognized including; classical pathway which mainly mediated AngII/AT1R detrimental effects. Conversely, non‐classical mostly ACE2/Ang1‐7/MASR AngII/AT2R beneficial effects against Exaggerated affects viability dopaminergic neurons. fundamental mechanism was not fully elucidated. Consequently, purpose this review to disclose mechanistic In addition, we try revise how ACEIs ARBs can developed for therapeutics

Язык: Английский

Процитировано

7

Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities DOI Creative Commons
Prasanna Srinivasan Ramalingam, Sujatha Elangovan, M. Janaki Ramaiah

и другие.

Frontiers in Cell and Developmental Biology, Год журнала: 2024, Номер 12

Опубликована: Март 14, 2024

Cancer has become a serious health burden that results in high incidence and mortality rates every year, mainly due to various molecular alterations inside the cell. Liver X receptors (LXRs) dysregulation is one among them plays vital role cholesterol metabolism, lipid metabolism inflammation also crucial diseases such as obesity, metabolic dysfunction-associated fatty liver disease (MAFLD), cardiovascular diseases, Type 2 diabetes, osteoporosis, cancer. Studies report activation of LXRs inhibits cancer growth by inhibiting cellular proliferation, inducing apoptosis autophagy, regulating signalling pathways Wnt, PI3K/AKT, modulating expression levels cell-cycle regulators, promoting antitumor immunity tumor microenvironment. In this review, we have discussed role, structure, functions summarized their ligands along with mechanism action. addition, cancers, microenvironment (TME) importance precision medicine LXR-targeted therapies been emphasize potent targets for development novel therapeutics.

Язык: Английский

Процитировано

6